 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

---
- Consumer-rights and personal injury law firm Hagens Berman has launched a nationwide
  investigation into CoolSculpting regarding the risk of permanent disfigurement and
  serious harm to patients bodies following treatment, which can include paradoxical
  adipose hyperplasia (PAH). The law firms...


Hagens Berman: Law Firm Investigating Permanent Injuries and Disfigurement from Botched CoolSculpting Procedures

---
- We spoke to two dermatologists and an ophthalmologist about what makes lash serums
  work, and which ones actually help grow fuller lashes. These are the five best,
  based on their recommendations.If you buy through our links, we may earn money from
  affiliate partners. Learn more.
- ''
- Latisse; NourishLash...


The best 5 eyelash serums for longer, fuller lashes, according to experts

---
- When it first hit in 2015, the estate owners sought $75 million.Richard Nixons former
  presidential compound along the shores of San Clemente is back on the market for
  $65 million.
- The figure is 13% more than the $57.5 million sought before the nine-bedroom, 14-bathroom
  Spanish Colonial Revival-style...


Richard Nixon's former Western White House relists for $65 million

---
- Hong Kong-listed R&amp;D service provider, Pharmaron Beijinghas agreed to acquireAllergan
  Biologics Limited for $118.7M in cash from AbbVie (ABBV).Subject to customary closing...


AbbVie to sell Allergan Biologics to Pharmaron for $119 million

AbbVie's Allergan Files US Application AGN-190584 For Presbyopia

---
- Dublin, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The "Facial Injectable Market - Forecasts
  from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering. The
  facial injectable market is projected to grow at a CAGR of 14.22% to reach US$21.727
  billion by 2025 from US$9.780 billion in 2019. ...


Worldwide Facial Injectable Industry to 2025 - by Type, Generation, End-user and Geography

Allergan's BOTOX Wins FDA Nod For Neurologic Condition-Associated Pediatric Detrusor Overactivity

---
- Allergan's exit from global breast implant markets, including Europe, Latin America
  and Southeast Asia, is a clear win for Establishment Labs (NASDAQ:ESTA) validating
  its product strategy.Jefferies analyst Raj Denhoy calls it as &#34;unexpected though
  rational move&#34; and maintains his Buy rating on the stock with price target of
  $50 and


Establishment Labs, a 2021 top idea on Allergan's global breast implant markets exit: Jefferies

---
- Allergan Aesthetics, an AbbVie company (NYSE:ABBV) enters into option to acquire
  Cypris Medical, a privately held, medical device company based in Chicago.


Allergan Aesthetics enters option to acquire a medical device company

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Market Cap	$63.66B
52-Wk High	$202.22
52-Wk Low	$114.27

AGN Allergan Inc.

About

Feed

News

Fundamentals